The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Looking for Brexit-proof portfolios? Try drugs, alcohol and tobacco

Wed, 29th Jun 2016 14:32

By Tricia Wright and Vikram Subhedar

LONDON, June 29 (Reuters) - Health, safety and even sometraditional 'sin stocks' have already shown signs of weatheringBrexit-related storms in European equity markets over the pastweek.

The flight to safety in the aftermath of last week's Brexitvote is sending investors scurrying back into healthcare andconsumer-related stocks that have shielded them from nearlyevery big market dislocation of the past five years.

On Wednesday, European healthcare became the first majorregional sector to recover all its post-Brexit losses, helpedlargely by the big UK bellwethers. Food and beverage stocks arepoised to follow.

Stocks such as AstraZeneca PLC, Diageo PLC and British American Tobacco PLC are up between 7percent and 11 percent since last Thursday's close.

They have led the broader market's recovery after more than$3 trillion was knocked off the value of global stocks in thetwo-day selloff that followed Britain's unexpected decision toleave the European Union.

The combination of dependable profits, dividends andexpectations that the weaker pound and euro will spur earningsupgrades for firms that sell mostly to consumers outside the UKand Europe has underpinned their resilience.

"There are three things at work but I think the first is thereach for dollar earnings," said Eric Moore, who runs the MitonIncome Fund from London.

"In a world where GDP is probably slowing everywhere,irrespective of Brexit, there's just more uncertainty," saidMoore, adding the relative stability of the so-called defensivesectors, whose profits are less reliant on economic growth,brightens their appeal.

The rally in bluechip healthcare and food and beveragestocks has even pushed the UK's FTSE 100 to less than apercent below its pre-Brexit level. In US dollar terms the indexis still more than 10 percent lower.

Outside of the UK, German real estate has found favour.Shares of Vonovia and Deutsche Wohnen areboth higher than where they were before last week's vote.

Both companies are focused on residential properties inGermany where low rates have contributed to steady price riseswhile low vacancy rates have put a floor under rents.

Gold mining stocks Rangold Resources and Fresnillo are up more than 20 percent as demand for the preciousmetal surged.

For a list of major European stocks that are above wherethey closed last Thursday see: http://reut.rs/295Lkwm

Goldman Sachs, which slashed its economic forecasts for theUK and Europe after the vote, now expects earnings in 2016 forthe Stoxx 600 to contract 5 percent.

Still, with German 10-year bund yields below zero the U.S.bank says equities offer value compared with other assets.

But given worries over the health of European banks andgrowth Goldman warns against broad-based buying and recommendsinvestors stick with food, beverage and tobacco and healthcareshares.

"The attractions of the more defensive or stable parts inequities are clear," said Goldman strategists in a note toclients.

(Reporting by Vikram Subhedar and Tricia Wright, additionalreporting by Tina Bellon in Frankfurt; Editing by Mike Dolan andToby Chopra)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.